Medium materiality6/10
Ionis Pharmaceuticals price target lowered to $87 from $104 at Raymond James
Why it may matterVerify against the original reporting
Bullish potential despite target cut.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target pulled back but remains above current price, suggesting upside potential for IONS with ongoing coverage.
- Raymond James lowers IONS target to $87; price $64.29; upside remains.
Key facts
- 01
Target: $87
- 02
Posted price: $64.29
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.